Active Ingredient
Trolamine Salicylate 10%
The following Structured Product Label (SPL) was submitted to the FDA by Telebrands Corp for the product Hempvana Maximum Strength Pain Relief - Platinum (NDC 73287-021). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, otc - when using, otc - stop use, otc - pregnancy or breast feeding, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Trolamine Salicylate 10%
Trolamine Salicylate 10%..........Topical Analgesic
temporarily relieves minor pain associated with:
For external use only
Allergy alert: If prone to allergic reaction from aspirin or salicylates, consult a doctor before use.
When using this product
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children and pets. If swallowed, get medical help or contact a Poison Control Center right away.
Water/Aqua/Eau, Ethylhexyl Stearate, Cannabis Sativa (Hemp) Seed Oil, Butylene Glycol, Stearic Acid, DImethicone, Caprylic/Capric Trigylceride, Glyceryl Stearate, PEG-100 Stearate, Cetearyl Alcohol, Helianthus Annuus (Sunflower) Seed Oil, Glycerin, Aloe Barbadensis Leaf Extract, Arnica Montana Flower Extract, Curcuma Longa (Turmeric) Root Extract, Dimethyl Sulfone, Tocopheryl Acetate, Phenoxyethanol, Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Caprylyl Glycol, Isohexadecane, Ethylhexylglycerin, Hexylene Glycol, Allantoin, Mannitol, Microcrystalline Cellulose, Iron Oxides Yellow (CI 77492), Tocopherol, Hydroxypropyl Methylcellulose, Ubiquinone, Polysorbate 80, Sodium Hydroxide, Disodium EDTA, Yellow 6 (CI 15985), Blue 1 (CI 42090)
Call (855) 877-4503 (M-F, 9am-5pm EST)
* Please review the disclaimer below.